Published in
Taylor and Francis Group, Expert Review of Pharmacoeconomics and Outcomes Research, 1(20), p. 1-26, 2020
DOI: 10.1080/14737167.2020.1734456
Links
Tools
Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
Journal article published in 2020 by
Brian Godman 
,
Holly McCabe,
Debjani Mueller,
Trudy D. Leong,
Renata Cristina Rezende Macedo do Nascimento ,
Antony P. Martin ,
Julius C. Mwita ,
Iris Hoxha,
Godfrey Mutashambara Rwegerera ,
Trudy D. Leong ,
Juliana de Oliveira Costa,
Amos Massele,
Renata Cristina Rezende Macedo do Nascimento,
Konstantin Tachkov ,
Juliana de Oliveira Costa
and other authors.
,
Holly McCabe,
Debjani Mueller,
Trudy D. Leong,
Renata Cristina Rezende Macedo do Nascimento ,
Antony P. Martin ,
Julius C. Mwita ,
Iris Hoxha,
Godfrey Mutashambara Rwegerera ,
Trudy D. Leong ,
Juliana de Oliveira Costa,
Amos Massele,
Renata Cristina Rezende Macedo do Nascimento,
Konstantin Tachkov ,
Juliana de Oliveira Costa
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 